Family Management’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Family Management’s Portfolio KERX Stock Details KERX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-20,000	Closed	-$68K	–	137
2018 Q3	$68K	Hold	20,000	–	–	0.04%	67
2018 Q2	$75K	Buy	+20,000	New	+$97.4K	0.05%	70
2016 Q2	–	Sell	-15,000	Closed	-$70K	–	87
2016 Q1	$70K	Buy	+15,000	New	+$59.9K	0.05%	69
2015 Q4	–	Sell	-20,000	Closed	-$70K	–	98
2015 Q3	$70K	Hold	20,000	–	–	0.03%	93
2015 Q2	$200K	Buy	+20,000	New	+$214K	0.08%	87

Family Management's KERX Position: Q4 2018 in Review

Family Management sold out of Keryx Biopharmaceuticals Inc (KERX) in Q4 2018, closing a stake of 20,000 shares — an estimated $68K sold.

Family Management first reported a position in KERX in Q2 2015 and held it in 5 quarters. The position peaked at $200K in Q2 2015. 1 fund tracked by Wall St. Rank holds KERX as of Q4 2018.

Family Management reported no remaining Keryx Biopharmaceuticals Inc position as of Q4 2018 after selling out during the quarter.
Family Management sold 20,000 Keryx Biopharmaceuticals Inc shares in Q4 2018, an estimated $68K.
Family Management first reported a position in Keryx Biopharmaceuticals Inc in Q2 2015 and held it in 5 quarters.
Family Management's Keryx Biopharmaceuticals Inc position peaked at $200K in Q2 2015.
1 fund tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q4 2018.

Based on Family Management's 13F filing for Q4 2018, filed 14 Feb 2019.